A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study

Autor: Yamada, Tadaaki, Goto, Yasuhiro, Tanaka, Hiroshi, Kimura, Hideharu, Minato, Koichi, Gyotoku, Hiroshi, Honda, Takeshi, Watanabe, Satoshi, Morimoto, Kenji, Kiyomi, Fumiaki, Uchino, Junji, Takayama, Koichi
Zdroj: In European Journal of Cancer December 2023 195
Databáze: ScienceDirect
Externí odkaz: